Priority Date: 22.04.10 (US 20100326695P)

OXAZOLE DERIVATIVES USEFUL AS MODULATORS OF FAAH

  • Application ID: EP11772492
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorney

no operation time available
4 offices
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Merck & Co. Inc. is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 22.04.2010 - Priority Date (US 20100326695P)
  • 27.10.2011 - Publication A1 (WO2011133447)
  • 22.05.2013 - Publication A1 (EP2593102)
  • 07.06.2017 - Publication B1 (EP2593102)